• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Synthetic Platelets Offer Potential Benefits for Platelet-Associated Disorders

July 20, 2012

Professor Nishit Doshi and colleagues from the University of California, Santa  Barbara, the Scripps Research Institute, and Sanford-Burnham Medical Research Institute have reported progress in developing synthetic platelets.  They synthesized platelets, imitating the size, shape, and adhesive properties, among other attributes, of mammalian platelets, and concluded that the synthetic particles were highly successful and could have major therapeutic applications.


Reference:

Doshi N, Orje JN, Molins B, Smith JW, Mitragorti S, Ruggeri ZM. Platelet Mimetic Particles for Targeting Thrombi in Flowing Blood. Adv Mater 2012.

Image Source:  Doshi N, Orje JN, Molins B, Smith JW, Mitragorti S, Ruggeri ZM. Platelet Mimetic Particles for Targeting Thrombi in Flowing Blood. Adv Mater 2012.

Filed Under

  • News
  • Platelet Transfusion

Recommended

  • Postpartum Hemorrhage and Predelivery Anemia are Risk Factors for Severe Postpartum Anemia after Cesarean Sections

  • Clinical Guidelines for Platelet Transfusions in Patients with Cancer

  • Platelet Extracellular Vesicles Formed During Storage May Be Causative Agents in Non-Antibody-Mediated TRALI

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Plasma Equivalent to Clotting Factor Concentrates for Initial Resuscitation of Patients with Severe Trauma

  • Personalized Prediction Model of Prophylactic Platelet Transfusions for Preterm Infants

  • Caffeine in Donor Blood Reduces Quality of Stored RBCs

  • Ferritin Levels Needed to Assess Hemoglobin Recovery after Blood Donation

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley